Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Barclays initiates Vipshop stock with overweight rating

EditorAhmed Abdulazez Abdulkadir
Published 11/06/2024, 08:38 AM
VIPS
-

On Wednesday, Barclays (LON:BARC) began coverage on shares of Vipshop Holdings (NYSE:NYSE:VIPS), assigning an Overweight rating to the stock along with a price target of $19.00. The firm's valuation of Vipshop is based on an enterprise value (EV) to nominal earnings before interest, taxes, depreciation, and amortization (EBITDA) approach, which is consistent with the valuation methods used for other companies in its coverage.

The Overweight rating reflects Barclays' view that Vipshop can maintain its profitability and achieve modest top-line growth despite a competitive retail landscape. The analyst cites a target nominal EBITDA margin of 10%, which is expected to support the company's bottom-line results.

Barclays' price target is derived from applying a multiple of 5 times EV/nominal EBITDA to Vipshop's forecasted fiscal year 2026 revenue, including net cash. This multiple is at a discount compared to peers such as JD (NASDAQ:JD).com, Alibaba (NYSE:BABA), and Pinduoduo (NASDAQ:PDD), given that Vipshop's business model is primarily focused on direct sales (1P) and does not significantly benefit from a high-margin advertising business.

The $19.00 price target suggests a positive outlook for Vipshop's stock performance. Barclays' analysis indicates confidence in the company's ability to navigate the challenges within the e-commerce sector while continuing to protect and potentially enhance its financial outcomes.

In other recent news, Vipshop Holdings has been the focus of several analyst adjustments. Citi raised its stock target to $18.00, maintaining a Buy rating, despite predicting a decrease in third-quarter revenues at the lower end of the company's guidance of a 5% to 10% decline.

The firm also decreased its non-GAAP net profit forecast for the third quarter by 6.2%. Similarly, HSBC reduced its price target for Vipshop to $14.20, maintaining a hold rating due to anticipated challenges in consumer demand, expecting a roughly 10% year-over-year decline in revenue for the second half of 2024.

JPMorgan reaffirmed its Overweight rating on Vipshop, suggesting limited downside risk for the stock's price based on its current valuation, while CLSA downgraded Vipshop's stock from Outperform to Hold, adjusting the price target to $12 from the previous $15.80.

Vipshop's second-quarter 2024 performance showed a 3.6% year-over-year decrease in total revenue, amounting to $26.9 billion, and an adjusted net profit of Rmb2.2 billion. The company's third-quarter guidance suggests a further revenue decline of 5-10% year-over-year. Yet, Vipshop announced a $1 billion share buyback program, demonstrating its commitment to shareholder value.

InvestingPro Insights

Barclays' optimistic outlook on Vipshop Holdings is supported by several key metrics from InvestingPro. The company's P/E ratio of 5.96 and PEG ratio of 0.44 for the last twelve months as of Q2 2024 indicate that the stock is trading at a low earnings multiple relative to its growth potential, aligning with Barclays' Overweight rating. This valuation perspective is further reinforced by an InvestingPro Tip highlighting that Vipshop is "Trading at a low P/E ratio relative to near-term earnings growth."

Despite Barclays' positive stance, it's worth noting that Vipshop's stock has faced some recent challenges, with a 1-month price total return of -16.4%. However, the company maintains a strong financial position, as evidenced by another InvestingPro Tip stating that Vipshop "Holds more cash than debt on its balance sheet." This financial stability could provide the company with flexibility to navigate the competitive retail landscape mentioned in Barclays' analysis.

For investors seeking a more comprehensive understanding of Vipshop's potential, InvestingPro offers 6 additional tips beyond those mentioned here, providing a deeper insight into the company's market position and financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.